CVRx, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CVRX research report →
Companywww.cvrx.com
CVRx, Inc. , a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF.
- CEO
- Kevin Hykes
- IPO
- 2021
- Employees
- 206
- HQ
- Minneapolis, MN, US
Price Chart
Valuation
- Market Cap
- $160.81M
- P/E
- -3.03
- P/S
- 2.72
- P/B
- 5.49
- EV/EBITDA
- -3.03
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 85.53%
- Op Margin
- -84.62%
- Net Margin
- -89.15%
- ROE
- -120.77%
- ROIC
- -55.38%
Growth & Income
- Revenue
- $56.65M · 10.45%
- Net Income
- $-53,306,000 · 11.10%
- EPS
- $-2.04 · 23.02%
- Op Income
- $-51,265,000
- FCF YoY
- -0.60%
Performance & Tape
- 52W High
- $11.30
- 52W Low
- $4.37
- 50D MA
- $7.68
- 200D MA
- $7.93
- Beta
- 0.87
- Avg Volume
- 334.99K
Get TickerSpark's AI analysis on CVRX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 27, 26 | Adamson Philip B. | other | 41,000 |
| Feb 27, 26 | Adamson Philip B. | other | 62,000 |
| Mar 2, 26 | Adamson Philip B. | sell | 1,262 |
| Mar 2, 26 | Morrison Gregory | other | 154,500 |
| Mar 2, 26 | Morrison Gregory | other | 34,000 |
| Mar 2, 26 | Morrison Gregory | other | 0 |
| Feb 27, 26 | Hykes Kevin | other | 159,000 |
| Mar 2, 26 | Hykes Kevin | sell | 7,763 |
| Feb 27, 26 | Hykes Kevin | other | 238,000 |
| Feb 27, 26 | VERRASTRO PAUL | other | 67,000 |
Our CVRX Coverage
We haven't published any research on CVRX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CVRX Report →